These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8896393)

  • 21. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
    Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
    Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD30-ligand and CD40-ligand expression in lymph nodes involved with Hodgkin's disease.
    Younes A; Zhao S; Zhang X; Snell V; Clodi K; Kliche KO; Thomas E; Cabanillas F; Andreeff M
    Ann Oncol; 1997; 8 Suppl 2():97-100. PubMed ID: 9209650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease.
    Gruss HJ; Hirschstein D; Wright B; Ulrich D; Caligiuri MA; Barcos M; Strockbine L; Armitage RJ; Dower SK
    Blood; 1994 Oct; 84(7):2305-14. PubMed ID: 7522624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro.
    Matsumoto K; Terakawa M; Miura K; Fukuda S; Nakajima T; Saito H
    J Immunol; 2004 Feb; 172(4):2186-93. PubMed ID: 14764685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases.
    Oflazoglu E; Grewal IS; Gerber H
    Adv Exp Med Biol; 2009; 647():174-85. PubMed ID: 19760074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trogocytosis of ligand-receptor complex and its intracellular transport in CD30 signalling.
    Nakashima M; Watanabe M; Uchimaru K; Horie R
    Biol Cell; 2018 May; 110(5):109-124. PubMed ID: 29431186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
    Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
    Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD30 is involved in inhibition of T-cell proliferation by Hodgkin's Reed-Sternberg cells.
    Su CC; Chiu HH; Chang CC; Chen JC; Hsu SM
    Cancer Res; 2004 Mar; 64(6):2148-52. PubMed ID: 15026356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
    Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
    Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma.
    Kim LH; Eow GI; Peh SC; Poppema S
    Pathology; 2003 Oct; 35(5):428-35. PubMed ID: 14555388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance.
    Clodi K; Asgari Z; Younes M; Palmer JL; Cabanillas F; Carbone A; Andreeff M; Younes A
    Cancer; 2002 Jan; 94(1):1-5. PubMed ID: 11815953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
    Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
    Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells.
    Hanamoto H; Nakayama T; Miyazato H; Takegawa S; Hieshima K; Tatsumi Y; Kanamaru A; Yoshie O
    Am J Pathol; 2004 Mar; 164(3):997-1006. PubMed ID: 14982853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and expression of a soluble form of human CD30 ligand with functional activity.
    Powell IF; Li T; Jäck HM; Ellis TM
    J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin's lymphoma-derived tumor cells.
    Heuser C; Diehl V; Abken H; Hombach A
    Int J Cancer; 2003 Sep; 106(4):545-552. PubMed ID: 12845650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand.
    Willers J; Dummer R; Kempf W; Kündig T; Burg G; Kadin ME
    Clin Cancer Res; 2003 Jul; 9(7):2744-54. PubMed ID: 12855655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression.
    Mori M; Manuelli C; Pimpinelli N; Mavilia C; Maggi E; Santucci M; Bianchi B; Cappugi P; Giannotti B; Kadin ME
    Blood; 1999 Nov; 94(9):3077-83. PubMed ID: 10556192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
    Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
    Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.